SYNVISC-ONE (Hylan G-F 20) - Synovial fluid supplementation substance

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Dostupné s:

Sanofi-Aventis Australia Pty Ltd

Třída:

Class III

Výrobce:

Genzyme Corporation 1125 Pleasant View Terrace, Ridgefield, NJ, 07657 United States Of America

Terapeutické oblasti:

44757 - Synovial fluid supplementation substance

Terapeutické indikace:

A sterile, nonpyrogenic, elastoviscous fluid containing hylan polycaccharide (Hylan polymer 8.0 mg/mL) hydrated in physiological saline. Synvisc-One is only intended for intra-articular use to treat pain associated with osteoarthritis of the knee.

Stav Autorizace:

A

Datum autorizace:

2009-02-09